Clinical Trial

Effects of Cistanche Supplementation on Anaerobic Exercise Performance and Recovery in Men With Different Athletic Training Levels

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study is a double-blind, randomized, placebo-controlled trial designed to examine whether 8 weeks of Cistanche deserticola supplementation, when combined with a standardized anaerobic training program, can improve anaerobic exercise performance, recovery, and selected body composition outcomes in young adult men with different athletic training levels. Participants will be assigned to receive either Cistanche deserticola extract or a matched placebo while completing the same supervised anaerobic training program. The study will assess changes in anaerobic performance, including Wingate test outcomes and jump performance, as well as recovery-related indicators such as blood lactate, creatine kinase, malondialdehyde, testosterone, cortisol, and the testosterone-to-cortisol ratio. Body composition outcomes, including body fat percentage and skeletal muscle mass, will also be evaluated. The purpose of this study is to determine whether Cistanche deserticola supplementation provides additional benefits beyond training alone, and whether these effects differ between highly trained and recreationally trained participants.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-20.
Status change: Completed → Not Yet Recruiting 2026-06-30
Trial Details
NCT Number NCT07546513
Lead Sponsor Beijing Sport University
Collaborators: Wuhan Sports University
Conditions Athlete, Elite Athlete, Sport Performance, Exercise Recovery
Enrollment 56 participants
Start Date 2026-06-25
Primary Completion 2026-09-01 (estimated)
Study Completion 2026-09-15 (estimated)
Updated on ClinicalTrials.gov 2026-07-02